1685 related articles for article (PubMed ID: 31545263)
1. Dexmedetomidine attenuates lipopolysaccharide induced acute lung injury in rats by inhibition of caveolin-1 downstream signaling.
Liu J; Huang X; Hu S; He H; Meng Z
Biomed Pharmacother; 2019 Oct; 118():109314. PubMed ID: 31545263
[TBL] [Abstract][Full Text] [Related]
2. The protective effect of dexmedetomidine on LPS-induced acute lung injury through the HMGB1-mediated TLR4/NF-κB and PI3K/Akt/mTOR pathways.
Meng L; Li L; Lu S; Li K; Su Z; Wang Y; Fan X; Li X; Zhao G
Mol Immunol; 2018 Feb; 94():7-17. PubMed ID: 29241031
[TBL] [Abstract][Full Text] [Related]
3. Dexmedetomidine protects against lung injury induced by limb ischemia-reperfusion via the TLR4/MyD88/NF-κB pathway.
Xue BB; Chen BH; Tang YN; Weng CW; Lin LN
Kaohsiung J Med Sci; 2019 Nov; 35(11):672-678. PubMed ID: 31373750
[TBL] [Abstract][Full Text] [Related]
4. Dexmedetomidine attenuates lipopolysaccharide-induced acute liver injury in rats by inhibiting caveolin-1 downstream signaling pathway.
Tong F; Shen W; Song P; Song J; Hu Y; Liu F; Meng Z; Liu J
Biosci Rep; 2021 Mar; 41(3):. PubMed ID: 33558888
[TBL] [Abstract][Full Text] [Related]
5. Dexmedetomidine ameliorates acute lung injury following orthotopic autologous liver transplantation in rats probably by inhibiting Toll-like receptor 4-nuclear factor kappa B signaling.
Chi X; Wei X; Gao W; Guan J; Yu X; Wang Y; Li X; Cai J
J Transl Med; 2015 Jun; 13():190. PubMed ID: 26070954
[TBL] [Abstract][Full Text] [Related]
6. Dexmedetomidine ameliorates LPS induced acute lung injury via GSK-3β/STAT3-NF-κB signaling pathway in rats.
Zhang H; Sha J; Feng X; Hu X; Chen Y; Li B; Fan H
Int Immunopharmacol; 2019 Sep; 74():105717. PubMed ID: 31254953
[TBL] [Abstract][Full Text] [Related]
7. Daidzein attenuates lipopolysaccharide-induced acute lung injury via toll-like receptor 4/NF-kappaB pathway.
Feng G; Sun B; Li TZ
Int Immunopharmacol; 2015 Jun; 26(2):392-400. PubMed ID: 25887269
[TBL] [Abstract][Full Text] [Related]
8. Kegan Liyan oral liquid ameliorates lipopolysaccharide-induced acute lung injury through inhibition of TLR4-mediated NF-κB signaling pathway and MMP-9 expression.
Zhang X; Sun CY; Zhang YB; Guo HZ; Feng XX; Peng SZ; Yuan J; Zheng RB; Chen WP; Su ZR; Huang XD
J Ethnopharmacol; 2016 Jun; 186():91-102. PubMed ID: 27036629
[TBL] [Abstract][Full Text] [Related]
9. Yemazhui () ameliorates lipopolysaccharide-induced acute lung injury modulation of the toll-like receptor 4/nuclear factor kappa-B/nod-like receptor family pyrin domain-containing 3 protein signaling pathway and intestinal flora in rats.
Li R; Yang H; Xue Y; Xianqin L
J Tradit Chin Med; 2024 Apr; 44(2):303-314. PubMed ID: 38504536
[TBL] [Abstract][Full Text] [Related]
10. Dexmedetomidine-mediated protection against septic liver injury depends on TLR4/MyD88/NF-κB signaling downregulation partly via cholinergic anti-inflammatory mechanisms.
Zi SF; Li JH; Liu L; Deng C; Ao X; Chen DD; Wu SZ
Int Immunopharmacol; 2019 Nov; 76():105898. PubMed ID: 31520992
[TBL] [Abstract][Full Text] [Related]
11. Effect of dexmedetomidine on kidney injury in sepsis rats through TLR4/MyD88/NF-κB/iNOS signaling pathway.
Jin YH; Li ZT; Chen H; Jiang XQ; Zhang YY; Wu F
Eur Rev Med Pharmacol Sci; 2019 Jun; 23(11):5020-5025. PubMed ID: 31210339
[TBL] [Abstract][Full Text] [Related]
12. Dexmedetomidine reduces ventilator-induced lung injury (VILI) by inhibiting Toll-like receptor 4 (TLR4)/nuclear factor (NF)-κB signaling pathway.
Chen H; Sun X; Yang X; Hou Y; Yu X; Wang Y; Wu J; Liu D; Wang H; Yu J; Yi W
Bosn J Basic Med Sci; 2018 May; 18(2):162-169. PubMed ID: 29510084
[TBL] [Abstract][Full Text] [Related]
13. Ulinastatin Protects Against LPS-Induced Acute Lung Injury By Attenuating TLR4/NF-κB Pathway Activation and Reducing Inflammatory Mediators.
Cao C; Yin C; Shou S; Wang J; Yu L; Li X; Chai Y
Shock; 2018 Nov; 50(5):595-605. PubMed ID: 29324628
[TBL] [Abstract][Full Text] [Related]
14. Fortunellin ameliorates LPS-induced acute lung injury, inflammation, and collagen deposition by restraining the TLR4/NF-κB/NLRP3 pathway.
Liu D; Guo R; Shi B; Chen M; Weng S; Weng J
Immun Inflamm Dis; 2024 Mar; 12(3):e1164. PubMed ID: 38501503
[TBL] [Abstract][Full Text] [Related]
15. Ulinastatin post-treatment attenuates lipopolysaccharide-induced acute lung injury in rats and human alveolar epithelial cells.
Luo Y; Che W; Zhao M
Int J Mol Med; 2017 Feb; 39(2):297-306. PubMed ID: 27959396
[TBL] [Abstract][Full Text] [Related]
16. Ferulic acid alleviates lipopolysaccharide-induced acute lung injury through inhibiting TLR4/NF-κB signaling pathway.
Wu X; Lin L; Wu H
J Biochem Mol Toxicol; 2021 Mar; 35(3):e22664. PubMed ID: 33140555
[TBL] [Abstract][Full Text] [Related]
17. Physalin B ameliorates inflammatory responses in lipopolysaccharide-induced acute lung injury mice by inhibiting NF-κB and NLRP3 via the activation of the PI3K/Akt pathway.
Zhong R; Xia T; Wang Y; Ding Z; Li W; Chen Y; Peng M; Li C; Zhang H; Shu Z
J Ethnopharmacol; 2022 Feb; 284():114777. PubMed ID: 34737012
[TBL] [Abstract][Full Text] [Related]
18. Taurine Alleviates LPS-Induced Acute Lung Injury by Suppressing TLR-4/NF-κB Pathway.
Zhao D; Zhang X; Feng Y; Bian Y; Fu Z; Wu Y; Ma Y; Li C; Wang J; Dai J; Fu Y; Lin S; Hu J
Adv Exp Med Biol; 2022; 1370():63-72. PubMed ID: 35882782
[TBL] [Abstract][Full Text] [Related]
19. Biochanin A protect against lipopolysaccharide-induced acute lung injury in mice by regulating TLR4/NF-κB and PPAR-γ pathway.
Hu X; Qin H; Li Y; Li J; Fu L; Li M; Jiang C; Yun J; Liu Z; Feng Y; Yao Y; Yin B
Microb Pathog; 2020 Jan; 138():103846. PubMed ID: 31698051
[TBL] [Abstract][Full Text] [Related]
20. Anti-inflammatory effects of Reduning Injection on lipopolysaccharide-induced acute lung injury of rats.
Tang LP; Xiao W; Li YF; Li HB; Wang ZZ; Yao XS; Kurihara H; He RR
Chin J Integr Med; 2014 Aug; 20(8):591-9. PubMed ID: 24916807
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]